Search clinical trials for: AML, chidamide, decitabine
Total 483 results
-
Chinese PLA General HospitalRecruitingPeripheral Blood Stem Cell TransplantationChina
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Chinese PLA General HospitalRecruiting
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Anhui Medical University; Henan Cancer Hospital and other collaboratorsRecruitingInduction Chemotherapy | Acute T-Lymphocytic Leukemia | T-cell Lymphoblastic Lymphoma Leukemia | T-cell/Myeloid Mixed Phenotype Acute LeukemiaChina
-
Zhejiang UniversityFirst People's Hospital of Hangzhou; Second Affiliated Hospital, School of... and other collaboratorsRecruiting
-
Shanghai Jiao Tong University School of MedicineNot yet recruiting
-
Chinese PLA General HospitalRecruitingNon Hodgkin LymphomaChina
-
University of WashingtonRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Secondary Myelofibrosis | Myeloproliferative Neoplasm, UnclassifiableUnited States
-
Beijing Tongren HospitalRecruitingExtranodal NK/T-cell LymphomaChina
-
Syntrix Biosystems, Inc.Johns Hopkins University; Mayo Clinic; National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingMyelodysplastic SyndromesUnited States
-
Chinese PLA General HospitalRecruiting
-
Benjamin TomlinsonRecruitingMyelodysplastic Syndromes | MDS/MPN Crossover SyndromesUnited States
-
Huihan WangRecruitingAcute Myeloid LeukemiaChina
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaboratorsRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Conditioning | TP53 | Myeloid TumorsChina
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaboratorsRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Conditioning | Myeloid TumorsChina
-
Michael SavonaIncyte Corporation; Astex Pharmaceuticals, Inc.; TheradexRecruiting
-
EpiDestiny, Inc.National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...RecruitingSickle Cell DiseaseUnited States
-
Dana-Farber Cancer InstitutePfizerRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Delta-Fly Pharma, Inc.RecruitingTrial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th SalvageLeukemia, Myeloid, AcuteUnited States
-
Massachusetts General HospitalAstex Pharmaceuticals, Inc.Recruiting
-
Ruijin HospitalRecruitingP53 Mutation | Myeloid Malignancy | MDS | AmlChina
-
University of ChicagoAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
Peking University People's HospitalRecruitingRefractory Leukemia | Stem Cell Transplant Complications | Relapse LeukemiaChina
-
Peking University People's HospitalRecruitingLeukemia, Myeloid, Acute | Stem Cell Transplant Complications | Leukemia RelapseChina
-
Xiqiang DangThe First Affiliated Hospital of Anhui Medical University; LanZhou University; Guangzhou First People's Hospital and other collaboratorsRecruitingChildren | Lupus Nephritis | Steroid | Immunosuppressive TreatmentChina
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer InstituteRecruitingAcute Myelogenous LeukemiaUnited States
-
University Hospital Schleswig-HolsteinUniversity of LuebeckRecruitingSplit-skin Grafted Third-degree Burn WoundGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid LeukemiaUnited States
-
Jacqueline Garcia, MDNational Institutes of Health (NIH)RecruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Hematopoietic Stem Cell Transplant | MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable)United States
-
The University of Texas Health Science Center,...RecruitingRecurrent EpendymomaUnited States
-
First Affiliated Hospital of Harbin Medical UniversityRecruiting
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingRecurrent, Platinum-resistant Ovarian CancerItaly
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsUnited States
-
Xuejie JiangRecruitingLeukemia, MyeloidChina
-
Chinese PLA General HospitalRecruitingHodgkin LymphomaChina
-
University of VirginiaMerck Sharp & Dohme LLC; Otsuka Pharmaceutical Development & Commercialization...RecruitingCTCL | PTCLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic LeukemiaUnited States
-
The University of Hong KongJanssen, LPRecruitingAcute Myeloid Leukemia | Complex KaryotypeHong Kong
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Beat AML, LLCRecruitingPreviously Untreated Acute Myeloid LeukemiaUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Astex Pharmaceuticals, Inc.; Institute of Cancer Research...RecruitingNon Small Cell Lung Cancer | Castration-Resistant Prostatic CancerUnited Kingdom
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Chinese PLA General HospitalRecruitingPrimary Malignant Neoplasm of Ovary | FIGO Stages II to IVChina
-
M.D. Anderson Cancer CenterRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingUntreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | High Risk Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Acute Myeloid... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Blasts More Than 20 Percent of Bone Marrow Nucleated Cells | Blasts More Than 20 Percent of Peripheral Blood White CellsUnited States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Astex Pharmaceuticals, Inc.Active, not recruitingAcute Myeloid LeukemiaUnited States, Spain, Canada